Canada Pension Plan Investment Board Evelo Biosciences, Inc. Transaction History

Canada Pension Plan Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$9.43 - $16.6 $235,750 - $415,000	-25,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $242,750 - $465,000	25,000 New	25,000 $268,000
Q4 2020 Feb 17, 2021	SELL	$3.91 - $12.28 $117,300 - $368,400	-30,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$3.81 - $5.73 $114,300 - $171,900	30,000 New	30,000 $158,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.